RXST
RxSight, Inc. NASDAQ Listed Jul 30, 2021$4.73
+3.05%
vs $4.59
Mkt Cap $194.8M
52w Low $4.59
1.5% of range
52w High $13.87
50d MA $6.09
200d MA $8.36
P/E (TTM)
—
EV/EBITDA
—
P/B
0.7x
Debt/Equity
0.0x
ROE
-14.1%
P/FCF
-10.1x
RSI (14)
35.40
ATR (14)
$0.29
Beta
1.21
50d MA
$6.09
200d MA
$8.36
Avg Volume
902.7K
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
100 Columbia · Aliso Viejo, CA 92656 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | -0.12 | -0.38 | -216.7% | 6.78 | -8.4% | -14.5% | +0.9% | -2.6% | -3.2% | +0.5% | — |
| Feb 25, 2026 | AMC | -0.33 | -0.22 | +34.3% | 8.81 | -13.6% | -10.1% | -5.6% | +1.7% | +0.1% | +4.1% | — |
| Nov 5, 2025 | AMC | -0.19 | -0.04 | +78.9% | 8.34 | +18.7% | +3.2% | +8.8% | +7.9% | +1.2% | -2.2% | — |
| Aug 7, 2025 | AMC | -0.10 | -0.08 | +20.0% | 7.79 | -4.4% | -7.7% | -7.5% | +10.5% | +13.1% | -1.1% | — |
| May 7, 2025 | AMC | -0.22 | -0.20 | +7.7% | 14.90 | +3.4% | -11.2% | -1.3% | +5.3% | -4.0% | +0.3% | — |
| Feb 25, 2025 | AMC | 0.10 | 0.03 | -70.0% | 29.21 | -6.1% | -0.8% | -2.6% | +0.5% | -5.0% | -0.3% | — |
| Nov 7, 2024 | AMC | -0.25 | -0.16 | +36.0% | 50.85 | -7.5% | -5.6% | -3.5% | -1.9% | -1.8% | -1.1% | — |
| Aug 5, 2024 | AMC | -0.22 | -0.16 | +27.3% | 40.78 | +23.6% | +17.3% | -3.4% | +6.7% | +2.8% | +2.8% | — |
| May 6, 2024 | AMC | -0.17 | -0.12 | +29.4% | 62.84 | +5.9% | -1.0% | -2.5% | +1.3% | -3.4% | -0.9% | — |
| Feb 28, 2024 | AMC | -0.36 | -0.26 | +27.8% | 56.39 | +2.4% | -3.2% | +2.1% | +0.7% | -2.9% | -1.4% | — |
| Nov 9, 2023 | AMC | -0.42 | -0.35 | +16.7% | 23.80 | -1.2% | +6.2% | +2.4% | +5.1% | +1.0% | +2.4% | — |
| Aug 7, 2023 | AMC | -0.47 | -0.40 | +14.9% | 28.84 | +11.0% | +2.7% | -6.8% | +1.2% | +0.8% | +4.9% | — |
| May 9, 2023 | AMC | -0.52 | -0.42 | +19.2% | 19.25 | +3.9% | +9.9% | +3.9% | +4.5% | -1.4% | +3.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9 | Stifel | Maintains | Hold → Hold | — | $7.69 | $7.36 | -4.3% | -1.6% | -0.8% | -1.6% | +3.4% | -4.1% |
| Feb 26 | UBS | Maintains | Neutral → Neutral | — | $8.81 | $7.61 | -13.6% | -10.1% | -5.6% | +1.7% | +0.1% | +4.1% |
| Feb 26 | Piper Sandler | Maintains | Neutral → Neutral | — | $8.81 | $7.61 | -13.6% | -10.1% | -5.6% | +1.7% | +0.1% | +4.1% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $8.81 | $7.61 | -13.6% | -10.1% | -5.6% | +1.7% | +0.1% | +4.1% |
| Jan 20 | Piper Sandler | Maintains | Neutral → Neutral | — | $9.81 | $9.79 | -0.2% | -1.5% | +3.0% | -0.9% | -3.5% | +0.4% |
| Dec 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $11.65 | $11.52 | -1.1% | +0.9% | +0.9% | +5.3% | +1.1% | -0.6% |
| Nov 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $8.34 | $9.90 | +18.7% | +3.2% | +8.8% | +7.9% | +1.2% | -2.2% |
| Nov 6 | Needham | Maintains | Buy → Buy | — | $8.34 | $9.90 | +18.7% | +3.2% | +8.8% | +7.9% | +1.2% | -2.2% |
| Nov 6 | JP Morgan | Maintains | Underweight → Underweight | — | $8.34 | $9.90 | +18.7% | +3.2% | +8.8% | +7.9% | +1.2% | -2.2% |
| Aug 8 | UBS | Maintains | Neutral → Neutral | — | $7.79 | $7.45 | -4.4% | -7.7% | -7.5% | +10.5% | +13.1% | -1.1% |
| Aug 8 | Stifel | Maintains | Hold → Hold | — | $7.79 | $7.45 | -4.4% | -7.7% | -7.5% | +10.5% | +13.1% | -1.1% |
| Aug 8 | Needham | Maintains | Buy → Buy | — | $7.79 | $7.45 | -4.4% | -7.7% | -7.5% | +10.5% | +13.1% | -1.1% |
| Jul 15 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $7.74 | $7.62 | -1.6% | -3.7% | -2.3% | +1.4% | -0.4% | +0.0% |
| Jul 10 | Jefferies | Downgrade | Buy → Hold | — | $7.95 | $7.97 | +0.3% | +6.4% | -5.4% | -3.2% | -3.7% | -2.3% |
| Jul 9 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $12.79 | $6.44 | -49.6% | -37.8% | +6.4% | -5.4% | -3.3% | -3.7% |
| Jul 9 | BofA Securities | Maintains | Underperform → Underperform | — | $12.79 | $6.44 | -49.6% | -37.8% | +6.4% | -5.4% | -3.3% | -3.7% |
| Jul 9 | Stifel | Maintains | Hold → Hold | — | $12.79 | $6.44 | -49.6% | -37.8% | +6.4% | -5.4% | -3.3% | -3.7% |
| Jul 9 | Piper Sandler | Maintains | Neutral → Neutral | — | $12.79 | $6.44 | -49.6% | -37.8% | +6.4% | -5.4% | -3.3% | -3.7% |
| Jul 9 | Needham | Maintains | Buy → Buy | — | $12.79 | $6.44 | -49.6% | -37.8% | +6.4% | -5.4% | -3.3% | -3.7% |
| Jul 9 | BTIG | Downgrade | Buy → Neutral | — | $12.79 | $6.44 | -49.6% | -37.8% | +6.4% | -5.4% | -3.3% | -3.7% |
| May 19 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $14.19 | $15.39 | +8.5% | +15.0% | +1.8% | -3.7% | -0.7% | -1.3% |
| Apr 9 | UBS | Downgrade | Buy → Neutral | — | $14.99 | $14.36 | -4.2% | +3.5% | -8.5% | -0.8% | +2.4% | +1.4% |
| Apr 8 | Needham | Maintains | Buy → Buy | — | $16.61 | $17.29 | +4.1% | -9.8% | +3.5% | -8.5% | -0.8% | +2.4% |
| Apr 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $16.26 | $15.42 | -5.2% | +2.2% | -9.8% | +3.5% | -8.5% | -0.8% |
| Apr 4 | JP Morgan | Downgrade | Overweight → Underweight | — | $16.21 | $15.17 | -6.4% | +0.3% | +2.2% | -9.8% | +3.5% | -8.5% |
| Apr 3 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $26.12 | $16.00 | -38.7% | -37.9% | +0.3% | +2.2% | -9.8% | +3.5% |
| Apr 3 | Needham | Maintains | Buy → Buy | — | $26.12 | $16.00 | -38.7% | -37.9% | +0.3% | +2.2% | -9.8% | +3.5% |
| Mar 21 | BofA Securities | Maintains | Buy → Buy | — | $24.90 | $24.35 | -2.2% | -0.2% | +0.3% | -0.9% | -1.3% | +9.4% |
| Mar 19 | Stifel | Maintains | Hold → Hold | — | $25.73 | $25.41 | -1.2% | -3.4% | +0.2% | -0.2% | +0.3% | -0.9% |
| Feb 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $29.21 | $27.44 | -6.1% | -0.8% | -2.6% | +0.5% | -5.0% | -0.3% |
| Feb 26 | Stifel | Maintains | Hold → Hold | — | $29.21 | $27.44 | -6.1% | -0.8% | -2.6% | +0.5% | -5.0% | -0.3% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $29.21 | $27.44 | -6.1% | -0.8% | -2.6% | +0.5% | -5.0% | -0.3% |
| Feb 26 | JP Morgan | Maintains | Overweight → Overweight | — | $29.21 | $27.44 | -6.1% | -0.8% | -2.6% | +0.5% | -5.0% | -0.3% |
| Jan 13 | Stifel | Maintains | Hold → Hold | — | $33.43 | $32.66 | -2.3% | -8.1% | -2.1% | +4.1% | -0.4% | -2.5% |
| Jan 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $33.43 | $32.66 | -2.3% | -8.1% | -2.1% | +4.1% | -0.4% | -2.5% |
| Jan 13 | Needham | Maintains | Buy → Buy | — | $33.43 | $32.66 | -2.3% | -8.1% | -2.1% | +4.1% | -0.4% | -2.5% |
| Dec 20 | Stifel | Downgrade | Buy → Hold | — | $38.19 | $35.41 | -7.3% | -11.9% | +2.8% | -0.3% | +1.7% | -2.4% |
| Dec 17 | Needham | Maintains | Buy → Buy | — | $38.49 | $38.30 | -0.5% | -1.2% | -2.2% | +2.7% | -11.9% | +2.8% |
| Dec 11 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $39.17 | $37.51 | -4.2% | -4.1% | -4.5% | +3.9% | +3.2% | -1.2% |
| Sep 13 | Needham | Maintains | Buy → Buy | — | $54.54 | $54.83 | +0.5% | +0.8% | +1.1% | +1.1% | -3.5% | -1.1% |
| Aug 20 | Needham | Maintains | Buy → Buy | — | $52.83 | $53.89 | +2.0% | +1.8% | -0.2% | +1.2% | +3.9% | -1.0% |
| Aug 6 | Needham | Maintains | Buy → Buy | — | $40.78 | $50.41 | +23.6% | +17.3% | -3.4% | +6.7% | +2.8% | +2.8% |
| Aug 6 | Stifel | Maintains | Buy → Buy | — | $40.78 | $50.41 | +23.6% | +17.3% | -3.4% | +6.7% | +2.8% | +2.8% |
| Aug 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $40.78 | $50.41 | +23.6% | +17.3% | -3.4% | +6.7% | +2.8% | +2.8% |
| Aug 6 | Oppenheimer | Maintains | Outperform → Outperform | — | $40.78 | $50.41 | +23.6% | +17.3% | -3.4% | +6.7% | +2.8% | +2.8% |
| Jul 15 | BTIG | Maintains | Buy → Buy | — | $47.72 | $48.95 | +2.6% | +1.9% | +1.6% | -4.5% | -2.5% | +1.6% |
| Jul 10 | Stifel | Maintains | Buy → Buy | — | $56.99 | $55.89 | -1.9% | -10.3% | -2.6% | -4.1% | +1.9% | +1.6% |
| May 7 | Needham | Maintains | Buy → Buy | — | $62.84 | $66.54 | +5.9% | -1.0% | -2.5% | +1.3% | -3.4% | -0.9% |
| May 7 | BTIG | Maintains | Buy → Buy | — | $62.84 | $66.54 | +5.9% | -1.0% | -2.5% | +1.3% | -3.4% | -0.9% |
| May 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $62.84 | $66.54 | +5.9% | -1.0% | -2.5% | +1.3% | -3.4% | -0.9% |
No insider trades available.
8-K
Unknown — 8-K Filing
A four-year vesting schedule for executive options incentivizes long-term retention at RXST, reducing near-term dilution while aligning management's interests with sustained stock performance.
Mar 19
8-K
RxSight, Inc. -- 8-K Filing
RxSight's 2025 LAL (light-adjustable lens) revenue grew strongly year-over-year, indicating successful market adoption and physician acceptance of their differentiated ophthalmic technology.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 1,530,050 | $16M | Reduced | Dec 2025 |
| 2 | Millennium Management | 2,059,459 | $13M | Reduced | Mar 2026 |
| 3 | Artisan Partners Limited Partnership | 2,058,684 | $13M | Reduced | Mar 2026 |
| 4 | Nomura Holdings Inc | 2,000,060 | $12M | — | Mar 2026 |
| 5 | D.e. Shaw & Co | 1,959,732 | $12M | Added | Mar 2026 |
| 6 | Vanguard Capital Management Llc | 1,692,935 | $10M | New | Mar 2026 |
| 7 | Two Sigma Investments, Lp | 1,300,260 | $8M | Added | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 1,210,039 | $7M | Added | Mar 2026 |
| 9 | Healthcare Of Ontario Pension Plan Trust Fund | 1,131,400 | $7M | Added | Mar 2026 |
| 10 | Citadel Advisors Llc | 1,118,719 | $7M | Added | Mar 2026 |
| 11 | Acadian Asset Management Llc | 1,019,127 | $6M | Added | Mar 2026 |
| 12 | Point72 Asset Management | 733,307 | $5M | Reduced | Mar 2026 |
| 13 | Aqr Capital Management Llc | 636,129 | $4M | Added | Mar 2026 |
| 14 | Walleye Capital Llc | 629,232 | $4M | Added | Mar 2026 |
| 15 | Jpmorgan Chase & Co | 488,641 | $3M | Added | Mar 2026 |
| 16 | Jane Street Group, Llc | 237,971 | $2M | Added | Dec 2025 |
| 17 | Vanguard Portfolio Management Llc | 335,802 | $2M | New | Mar 2026 |
| 18 | Northern Trust Corp | 317,761 | $2M | Added | Mar 2026 |
| 19 | Tocqueville Asset Management L.p. | 310,000 | $2M | Added | Mar 2026 |
| 20 | Bnp Paribas Financial Markets | 304,788 | $2M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$194.8M
Enterprise Value
-$23.5M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.33x
P/B
0.71x
P/S
1.53x
P/FCF
-10.07x
EV/EBITDA
—
Shares Out
41.2M
Financials (TTM)
Revenue
$127.5M
Net Income
-$46.6M
EBITDA
-$43.2M
Free Cash Flow
-$19.3M
Op Cash Flow
-$15.5M
EPS Basic
$-0.95
EPS Diluted
$-1.13
EPS Forward
$-1.32
Gross Margin
77.0%
Op Margin
-43.4%
Net Margin
-36.6%
Balance Sheet
Total Assets
$311.8M
Total Liab.
$36.1M
Total Equity
$275.7M
Cash
$228.1M
LT Debt
$9.9M
Book Value/Sh
$6.70
Debt/Equity
0.04x
Current Ratio
10.95
Quick Ratio
9.75
Returns & Growth
ROE
-14.1%
ROA
-12.5%
ROIC
-16.8%
Rev Growth YoY
-3.9%
EPS Growth YoY
-33.8%
Price Returns
2W
-5.3%
1M
-24.6%
3M
-28.7%
6M
-53.3%
12M
-65.1%
Technicals
52W High
$13.87
52W Low
$4.59
50d MA
$6.09
200d MA
$8.36
RSI (14)
35.40
ATR (14)
$0.29
Beta
1.21
Avg Volume
903K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$10.75
High
$13.00
Low
$9.00
Median
$10.50
Data updated apr 26, 2026 11:50pm
· Source: financialmodelingprep.com